Barbara Goff, MD, on the Ovarian Cancer Symptoms Study
Barbara Goff, MD, on the Ovarian Cancer Symptoms Study
Dr. Barbara Goff was recently interviewed by OCRF's CEO Elizabeth Howard about her work on her ovarian cancer symptoms study.
Dr. Barbara Goff was recently interviewed by OCRF's CEO Elizabeth Howard about her work on her ovarian cancer symptoms study.
This is the first in a series of interviews conducted by OCRF's Chief Executive Officer, Elizabeth Howard.
He was interviewed on May 26, 2009, by OCRF's Chief Executive Officer, Elizabeth Howard.
She was interviewed by OCRF's CEO Elizabeth Howard on June 2nd.
She spoke with OCRF's CEO, Elizabeth Howard, about stem cell research and ovarian cancer.
A study of 3,000 women found that those expose to more ultraviolet radiation had a decreased risk of ovarian cancer and an increased risk of borderline tumors. See the full abstract here
10/04/2012 OCRF Grantee Daniela Dinulescu, PhD Research funded by OCRF and published in the Sept. 27 edition of PNaS suggests that the Notch3 signaling pathway plays an important role in the maintenance of cancer stem cells (CSCs) and platinum resistance in ovarian cancer. OCRF grantee Daniela Dinulescu, PhD of Brigham and Women’s Hospital in Boston, was the … Continued
One of the Ovarian Cancer National Alliance’s newest Partner Members, Ovarcome Non-Profit Inc., has made great strides in its first year. Founder and President Runsi Sen was inspired by her mother Atashi’s battle with ovarian cancer. Like many women, Atashi was diagnosed when her disease was already advanced, and she passed away within a year. … Continued
According to a study done by the Fred Hutchison Cancer Cancer, a quick three-question survey as part of patient intake can help women with the symptoms of ovarian cancer be diagnosed with the disease sooner. The survey asks women if they have had abdominal/pelvic pain, feel full quickly when they eat and/or abdominal bloating. Women … Continued
09/25/2012 In a new study of 825 women published in the prestigious journal Nature, members of The Cancer Genome Atlas Network identified four major biological subtypes of breast cancer: luminal A, luminal B, HER2 “enriched,” and basal-like. Basal-like tumors were found to be more like an aggressive form of ovarian cancer, high grade serous ovarian … Continued
09/25/2012 Research published in the Oct. 2012 Journal of Evidence-Based Complementary and Alternative Medicine showed that ovarian cancer survivors who “participated in both regular exercise and yoga had higher scores in physical functioning, fewer limitations with physical and emotional health, less pain, and more vitality than survivors who reported participating in regular exercise only. These … Continued
Recognizing the community’s concern about the USPSTF recommendation regarding screening for ovarian cancer in September 2012, OCRF responded by writing a New York Times Letter to the Editor to reinforce the fact that research is the key and expand our message to a much wider audience. It was published on September 21, 2012.
Get email updates about research news, action alerts, and ways to join the fight.
A global, Al-powered ecosystem designed to transform gynecologic cancer research—connecting patients, researchers, and clinicians to accelerate breakthroughs.
Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.